Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease

NCT04713982 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04713982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
November 19, 2021
Completion date
October 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease